192 related articles for article (PubMed ID: 11502830)
1. Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.
Kearney T; Navas de Gallegos C; Chrisoulidou A; Gray R; Bannister P; Venkatesan S; Johnston DG
J Clin Endocrinol Metab; 2001 Aug; 86(8):3900-6. PubMed ID: 11502830
[TBL] [Abstract][Full Text] [Related]
2. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
3. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism.
Chrisoulidou A; Kousta E; Venkatesan S; Gray R; Bannister PA; Gallagher JJ; Lawrence N; Johnston DG
Metabolism; 2000 May; 49(5):563-6. PubMed ID: 10831163
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.
O'Neal D; Hew FL; Sikaris K; Ward G; Alford F; Best JD
J Clin Endocrinol Metab; 1996 Jul; 81(7):2448-54. PubMed ID: 8675559
[TBL] [Abstract][Full Text] [Related]
6. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency.
Cummings MH; Christ E; Umpleby AM; Albany E; Wierzbicki A; Lumb PJ; Sönksen PH; Russell-Jones DL
J Clin Endocrinol Metab; 1997 Jun; 82(6):2010-3. PubMed ID: 9177423
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
10. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
12. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
14. Influence of obesity on the metabolism of apolipoprotein B in humans.
Egusa G; Beltz WF; Grundy SM; Howard BV
J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome.
Taskinen MR; Nikkilä EA; Pelkonen R; Sane T
J Clin Endocrinol Metab; 1983 Sep; 57(3):619-26. PubMed ID: 6348067
[TBL] [Abstract][Full Text] [Related]
18. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
19. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study.
Christ ER; Cummings MH; Stolinski M; Jackson N; Lumb PJ; Wierzbicki AS; Sönksen PH; Russell-Jones DL; Umpleby AM
Eur J Endocrinol; 2006 Mar; 154(3):459-66. PubMed ID: 16498060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
